Chemotherapy: What is its role in meningioma?
- PMID: 23082735
- DOI: 10.1586/ern.12.108
Chemotherapy: What is its role in meningioma?
Abstract
While strong evidence exists for the standard therapy for meningiomas, inclusive of surgery and/or radiation therapy, for those tumors which recur, progress or are inoperable, the optimal medical therapies are yet to be elucidated. This article reviews the current literature for chemotherapeutic options for this subset of tumors, including cytotoxic agents, biologic agents, targeted molecular agents and hormonal agents. At this point in time, the most data is with hydroxyurea and somatostatin, although further trials with combination and targeted molecular therapies are still underway.
Similar articles
-
Medical treatment of recurrent meningiomas.Expert Rev Neurother. 2011 Oct;11(10):1425-32. doi: 10.1586/ern.11.38. Expert Rev Neurother. 2011. PMID: 21955199 Review.
-
The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma.Curr Opin Oncol. 2012 Nov;24(6):666-71. doi: 10.1097/CCO.0b013e328356364d. Curr Opin Oncol. 2012. PMID: 22759739 Review.
-
Hydroxyurea chemotherapy in the treatment of meningiomas.Neurosurg Focus. 2007;23(4):E11. doi: 10.3171/FOC-07/10/E11. Neurosurg Focus. 2007. PMID: 17961035 Review.
-
Treatment of high risk or recurrent meningiomas with hydroxyurea.J Clin Neurosci. 2002 Mar;9(2):156-8. doi: 10.1054/jocn.2001.1019. J Clin Neurosci. 2002. PMID: 11922703
-
Novel therapies for meningiomas.Expert Rev Neurother. 2006 Oct;6(10):1447-64. doi: 10.1586/14737175.6.10.1447. Expert Rev Neurother. 2006. PMID: 17078786 Review.
Cited by
-
An Overview of Managements in Meningiomas.Front Oncol. 2020 Aug 21;10:1523. doi: 10.3389/fonc.2020.01523. eCollection 2020. Front Oncol. 2020. PMID: 32974188 Free PMC article. Review.
-
RACK1 Promotes Meningioma Progression by Activation of NF-κB Pathway via Preventing CSNK2B from Ubiquitination Degradation.Cancers (Basel). 2024 Feb 13;16(4):767. doi: 10.3390/cancers16040767. Cancers (Basel). 2024. PMID: 38398158 Free PMC article.
-
Identification of key genes of anti-programmed death ligand 1 for meningioma immunotherapy by bioinformatic analysis.Med Oncol. 2022 Dec 20;40(1):54. doi: 10.1007/s12032-022-01869-8. Med Oncol. 2022. PMID: 36538194 Free PMC article.
-
Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo.Cancers (Basel). 2021 Nov 24;13(23):5898. doi: 10.3390/cancers13235898. Cancers (Basel). 2021. PMID: 34885009 Free PMC article.
-
Consensus core clinical data elements for meningiomas (v2021.1).Neuro Oncol. 2022 May 4;24(5):683-693. doi: 10.1093/neuonc/noab259. Neuro Oncol. 2022. PMID: 34791428 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources